Skip to main content

Jaehyung Park

Sungkyunkwan University · Medicine

About the Lab

Professor Jaehyung Park's research lab specializes in cancer nanomedicine, focusing on the development of stimuli-responsive and targeted nanotherapeutics for effective cancer treatment. The lab explores innovative strategies such as sonodynamic therapy, ROS-responsive drug delivery, and tumor microenvironment-targeting nanomaterials to enhance therapeutic precision and reduce systemic toxicity. Key research directions include designing functional nanocomposites—like Au-TiO₂ and hyaluronic acid-based nanoparticles—for improved tumor targeting, controlled drug release, and activation by ultrasound or enzymatic stimuli. The lab also investigates the interplay between cancer metabolism and nanotherapeutic efficacy, aiming to translate basic discoveries into clinical applications.

cancer nanomedicinesonodynamic therapystimuli-responsive nanomaterialstargeted drug deliveryreactive oxygen species

Research Overview

Papers
427
Total Citations
36,021
Papers (5y)
75
Primary Field
Medicine

Research Output Trend

Figures are computed from collected data and may differ slightly.

Publications per year (5y)
75total
2021
2022
2023
2024
2025
Citations per year (5y)
3,710total
20212022202320242025

Selected Papers

15
1
Review|814 citations·2009
Targeted delivery of low molecular drugs using chitosan and its derivatives
Jae Hyung Park, Gurusamy Saravanakumar, Kwangmeyung Kim, Ick Chan Kwon
SJR Q1Advanced Drug Delivery Reviews
BiomaterialsMaterials Science
2
Review|568 citations·2020
Cancer Metabolism: Phenotype, Signaling and Therapeutic Targets
Jae Hyung Park, Woo Yang Pyun, Hyun Woo Park
SJR Q1CellsOA

Aberrant metabolism is a major hallmark of cancer. Abnormal cancer metabolism, such as aerobic glycolysis and increased anabolic pathways, has important roles in tumorigenesis, metastasis, drug resistance, and cancer stem cells. Well-known oncogenic signaling pathways, such as phosphoinositide 3-kinase (PI3K)/AKT, Myc, and Hippo pathway, mediate metabolic gene expression and increase metabolic enzyme activities. Vice versa, deregulated metabolic pathways contribute to defects in cellular signal

Cancer ResearchBiochemistry, Genetics and Molecular Biology
3
Article|559 citations·2009
Self-assembled hyaluronic acid nanoparticles for active tumor targeting
Ki Young Choi, Hyunjin Chung, Kyung Hyun Min, Hong Yeol Yoon, Kwangmeyung Kim, Jae Hyung Park, Ick Chan Kwon, Seo Young Jeong
SJR Q1Biomaterials
Cell BiologyBiochemistry, Genetics and Molecular Biology
4
Article|491 citations·2007
Polymeric nanomedicine for cancer therapy
Jae Hyung Park, Seulki Lee, Jong‐Ho Kim, Kyeongsoon Park, Kwangmeyung Kim, Ick Chan Kwon
SJR Q1Progress in Polymer Science
BiomaterialsMaterials Science
5
Article|486 citations·2013
Measurement of a solid-state triple point at the metal–insulator transition in VO2
Jae Hyung Park, Jim M. Coy, T. Serkan Kasırga, Chunming Huang, Zaiyao Fei, Scott Hunter, David Cobden
SJR Q1NatureOA
Polymers and PlasticsMaterials Science
6
Review|402 citations·2015
Polysaccharide-based nanoparticles for theranostic nanomedicine
Maggie Swierczewska, Hwa Seung Han, Kyungmok Kim, Jae Hyung Park, S. Lee
SJR Q1Advanced Drug Delivery ReviewsOA
BiomaterialsMaterials Science
7
Article|401 citations·2016
Long-Circulating Au-TiO2Nanocomposite as a Sonosensitizer for ROS-Mediated Eradication of Cancer
V. G. Deepagan, Dong Gil You, Wooram Um, Hyewon Ko, Seunglee Kwon, Ki Young Choi, Gi‐Ra Yi, Jun Young Lee, Doo Sung Lee, Kwangmeyung Kim, Ick Chan Kwon, Jae Hyung Park
SJR Q1Nano Letters

Although sonodynamic therapy (SDT) has emerged as a potential alternative to conventional photodynamic therapy, the low quantum yield of the sonosensitizer such as TiO 2 nanoparticles (NPs) is still a major concern. Here, we have developed hydrophilized Au-TiO 2 nanocomposites (HAu-TiO 2 NCs) as sonosensitizers for improved SDT. The physicochemical properties of HAu-TiO 2 NCs were thoroughly studied and compared with their counterparts without gold deposition. Upon exposure of HAu-TiO 2 NCs to u

Biomedical EngineeringEngineering
8
Article|395 citations·2011
Smart Nanocarrier Based on PEGylated Hyaluronic Acid for Cancer Therapy
Ki Young Choi, Hong Yeol Yoon, Jong‐Ho Kim, Sang Mun Bae, Rang‐Woon Park, Young Mo Kang, In-San Kim, Ick Chan Kwon, Kuiwon Choi, Seo Young Jeong, Kwangmeyung Kim, Jae Hyung Park
SJR Q1ACS Nano

Tumor targetability and site-specific drug release of therapeutic nanoparticles are key factors for effective cancer therapy. In this study, poly(ethylene glycol) (PEG)-conjugated hyaluronic acid nanoparticles (P-HA-NPs) were investigated as carriers for anticancer drugs including doxorubicin and camptothecin (CPT). P-HA-NPs were internalized into cancer cells (SCC7 and MDA-MB-231) via receptor-mediated endocytosis, but were rarely taken up by normal fibroblasts (NIH-3T3). During in vitro drug r

BiomaterialsMaterials Science
9
Article|357 citations·2019
Nanomedicines for Reactive Oxygen Species Mediated Approach: An Emerging Paradigm for Cancer Treatment
Seunglee Kwon, Hyewon Ko, Dong Gil You, Kazunori Kataoka, Jae Hyung Park
SJR Q1Accounts of Chemical Research

Growth in the knowledge of cancer biology has led to the emergence and evolution of cancer nanomedicines by providing the rationale for leveraging nanotechnology to develop better treatment options. The discovery of nanometer-sized intercellular openings in the defective angiogenic tumor vasculature contributed to the development of an idea for the well-known cancer passive targeting regime, enhanced permeability and retention (EPR) effect, of the nanomedicines. Recently, reactive oxygen species

Biomedical EngineeringEngineering
10
Article|350 citations·2013
Hypoxia-responsive polymeric nanoparticles for tumor-targeted drug delivery
Thavasyappan Thambi, V. G. Deepagan, Hong Yeol Yoon, Hwa Seung Han, Seol-Hee Kim, Soyoung Son, Dong‐Gyu Jo, Cheol-Hee Ahn, Yung Doug Suh, Kwangmeyung Kim, Ick Chan Kwon, Doo Sung Lee
SJR Q1Biomaterials
Biomedical EngineeringEngineering
11
Article|349 citations·2010
Tumor-homing multifunctional nanoparticles for cancer theragnosis: Simultaneous diagnosis, drug delivery, and therapeutic monitoring
Kwangmeyung Kim, Jong Ho Kim, Hyungkyu Park, Yoo-Shin Kim, Kyeongsoon Park, Heayun Nam, Seulki Lee, Jae Hyung Park, Rang‐Woon Park, In-San Kim
SJR Q1Journal of Controlled Release
BiomaterialsMaterials Science
12
Article|331 citations·2010
PEGylation of hyaluronic acid nanoparticles improves tumor targetability in vivo
Ki Young Choi, Kyung Hyun Min, Hong Yeol Yoon, Kwangmeyung Kim, Jae Hyung Park, Ick Chan Kwon, Kuiwon Choi, Seo Young Jeong
SJR Q1Biomaterials
BiomaterialsMaterials Science
13
Article|322 citations·2016
ROS-generating TiO2 nanoparticles for non-invasive sonodynamic therapy of cancer
Dong Gil You, V. G. Deepagan, Wooram Um, Sangmin Jeon, Sejin Son, Hyeyoun Chang, Hwa In Yoon, Yong Woo Cho, Maggie Swierczewska, Seulki Lee, Martin G. Pomper, Ick Chan Kwon
SJR Q1Scientific ReportsOA

The non-invasive photodynamic therapy has been limited to treat superficial tumours, primarily ascribed to poor tissue penetration of light as the energy source. Herein, we designed a long-circulating hydrophilized titanium dioxide nanoparticle (HTiO2 NP) that can be activated by ultrasound to generate reactive oxygen species (ROS). When administered systemically to mice, HTiO2 NPs effectively suppressed the growth of superficial tumours after ultrasound treatments. In tumour tissue, the levels

Biomedical EngineeringEngineering
14
Review|319 citations·2019
Hyaluronic Acid–Based Activatable Nanomaterials for Stimuli‐Responsive Imaging and Therapeutics: Beyond CD44‐Mediated Drug Delivery
Ki Young Choi, Hwa Seung Han, Eun Sook Lee, Jung Min Shin, Benjamin D. Almquist, Doo Sung Lee, Jae Hyung Park
SJR Q1Advanced Materials

There is a rapidly increasing interest in developing stimuli-responsive nanomaterials for treating a variety of diseases. By enabling the activation of function locally at the sites of interest, it is possible to increase therapeutic efficacy significantly while simultaneously reducing adverse side effects. While there are many sophisticated nanomaterials available, they are often highly complex and not easily transferrable to industrial scales and clinical settings. However, nanomaterials based

Cell BiologyBiochemistry, Genetics and Molecular Biology
15
Review|310 citations·2005
Biodegradable Polymers for Microencapsulation of Drugs
Jae Hyung Park, Mao Ye, Kyung‐Min Park
SJR Q1MoleculesOA

Drug delivery has become increasingly important mainly due to the awareness of the difficulties associated with a variety of old and new drugs. Of the many polymeric drug delivery systems, biodegradable polymers have been used widely as drug delivery systems because of their biocompatibility and biodegradability. The majority of biodegradable polymers have been used in the form of microparticles, from which the incorporated drug is released to the environment in a controlled manner. The factors

Pharmaceutical SciencePharmacology, Toxicology and Pharmaceutics

Research Areas

BiomaterialsMolecular BiologyBiomedical EngineeringHepatologyElectrical and Electronic EngineeringCardiology and Cardiovascular Medicine

Dive deeper into Jaehyung Park's research on Nubint

Open this lab's papers in the app to read with AI, summarize, and cite in your writing.